NCT02726360

Brief Summary

The purpose of this study is to test a method for analyzing interactions between patients and doctors, the Roter Interaction Analysis System (RIAS). The RIAS measures the quality of communication between patients and their cancer doctors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2015

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2016

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 1, 2016

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2023

Completed
Last Updated

August 23, 2023

Status Verified

August 1, 2023

Enrollment Period

7.7 years

First QC Date

March 15, 2016

Last Update Submit

August 22, 2023

Conditions

Keywords

Communication15-316PhysicianUseNon-EnglishLanguage Skills

Outcome Measures

Primary Outcomes (1)

  • study-specific coding structure

    using the RIAS in cancer care across English and Spanish languages will be assessed by evaluating whether this existing, validated coding system 'works' across a language barrier.

    2 years

Study Arms (2)

Oncology physician

Physicians (MD or DO) in the oncology departments of participating hospitals will complete a survey. Non-English language proficiency will be assessed by self-assessment using Interagency Language Roundtable (ILR) scale, which the PI has previously used. The physician survey is collected among treating physicians of patients enrolled to MSK IRB approved protocols 12-099 and 12-223 at some of the participating hospitals. For physicians who already completed this survey as part of participation in protocol 12-099 or 12-223, data will be extracted from the respective study's REDCap database.

Behavioral: surveyBehavioral: Audio record

patients

Audio record the initial visits between patients and their treating physician. Analyze 48 patient-physician dyad recordings using the Roter Interaction Analysis System (RIAS).

Behavioral: Audio record

Interventions

surveyBEHAVIORAL

The ILR Scale, a non-English language proficiency self-assessment.

Also known as: ILR Scale
Oncology physician
Audio recordBEHAVIORAL

Audio record the initial visits between patients and their treating physician

Oncology physicianpatients

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will enroll all treating physicians of participating sites who are likely to treat LEP Spanish-speaking patients. All patient recruitment will be done by bilingual research staff who are consenting professionals with (when necessary) a volunteer affiliation with the collaborating study site.

You may qualify if:

  • is a English or Spanish-speaking patient
  • between the ages of 21-80 years old
  • has a new diagnosis of any type of cancer (diagnosed within the past 4 months), or has a recurrence of either breast, colon or lung cancer (recurrence diagnosed within the past 4 months)
  • scheduled to have surgery or begin chemotherapy and/or radiation therapy within the next 2 months
  • provides care to LEP patients
  • has MD, DO, RN, NP or PA degree
  • is between the ages of 21-80

You may not qualify if:

  • is unable to provide informed consent in either English or Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Queens Cancer Center of Queens Hospital

Jamaica, New York, 11432, United States

Location

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Ralph Lauren Center for Cancer Care and Prevention

New York, New York, United States

Location

Elmhurst Hospital Center

Queens, New York, 11373, United States

Location

Lincoln Medical Center

The Bronx, New York, United States

Location

Related Links

MeSH Terms

Conditions

Breast NeoplasmsColonic NeoplasmsLung NeoplasmsCommunication

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Lisa Diamond, MD, MPH

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2016

First Posted

April 1, 2016

Study Start

December 14, 2015

Primary Completion

August 21, 2023

Study Completion

August 21, 2023

Last Updated

August 23, 2023

Record last verified: 2023-08

Locations